How the availability of vast distribution channels propels the growth of the Dermatology Drug market in Middle-East and Africa?

 The growth of the Middle East and Africa dermatology drug market is driven by the escalating occurrence of skin diseases and disorders across the country. Additionally, rising awareness regarding the availability of various skincare drugs and the booming demand for skincare products for curing skin disorders will fuel the growth of the market. Further, the growing trend of having a better skin appearance increases the demand for dermatological drugs. The introduction of customer-centric products is likely to provide the opportunity for the significant growth of the market. The Middle-East and Africa Dermatology Drug Market is expected to grow at a CAGR of 7% during 2021-26.

Based on Application, the psoriasis segment is anticipated to grow at a substantial rate owing to the increasing government initiative to create psoriasis awareness among people, genetic disposition, and rise in the ageing population. Moreover, a rise in the practice of unhealthy lifestyles such as consumption of alcohol, smoking, and high-stress level is the major factor which is supposed to trigger psoriasis. This eventually increases the demand for the dermatological drug.

Based on Drug Class, Corticosteroids hold the highest market share in the Middle-East and Africa dermatology drug market during the forecasted period as it is used in case of most prevalent skin problems such as itching, redness, and allergic reactions. 



 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Based on Region, South-Africa acquired the largest market share in the Middle-East and Africa dermatology drug market attributing to the high demand for dermatology drugs due to the increase in the number of cases suffering from chronic skin diseases. Moreover, the surge in government initiatives for the development of necessary infrastructure to support the pharmaceutical industry propels the growth of the dermatology drug market.


The major leading players in the Middle East and Africa Dermatology Drug Market are Bausch Health Companies Inc., Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Merck & Co. Inc., Amgen Inc., AbbVie Inc., Eli Lilly and Company, Galderma S.A., GlaxoSmithKline plc, Mylan N.V.


Comments

Popular posts from this blog

How Rise in Number of Internet Users Fuels the Growth of the GCC E-Pharmacies Market?

Increasing Inclination of Oncologists and Physician to opt for Non-Invasive Diagnostic Procedures is Anticipated to Propel the Growth of the Global Liquid Biopsy market

Snowballing Demand for Medical Plastics in the Disposable Medical Products is Anticipated to Propel the Growth of Medical Plastic Converters market